151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old

BACKGROUND: Pneumococcal conjugate vaccine (PCV13) was recommended in series with PPSV23 for all US adults ≥65 years in late 2014. We evaluated effectiveness of PCV13 against invasive pneumococcal disease (IPD) among Medicare beneficiaries ≥65 years old to assess this new policy. METHODS: We linked...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilishvili, Tamara, Almendares, Olivia M, Nanduri, Srinivas, Warnock, Rob, Wu, Xiyuan, McKean, Stephen, Kelman, Jeffrey, Farley, Monica M, Schaffner, William, Thomas, Ann, Reingold, Arthur, Harrison, Lee H, Holtzman, Corinne, Rowlands, Jemma V, Petit, Susan, Barnes, Meghan, Torres, Salina, Beall, Bernard, Whitney, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252531/
http://dx.doi.org/10.1093/ofid/ofy209.021

Ejemplares similares

Ejemplares similares